| Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 79281646 | FILING DATE | 01/28/2020 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | 1521536 | INTL REG DATE | 01/28/2020 |
| TM ATTORNEY | STADELI, MARTA ANN |
L.O. ASSIGNED | N50-NOT FOUND |
PUB INFORMATION |
|||
| RUN DATE | 05/28/2020 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 05/27/2020 | ||
| LITERAL MARK ELEMENT | VIJOICE | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | NO | 1 (b) | NO | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | YES | 66A | YES | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | VIJOICE |
| MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | YES |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | NOVARTIS AG |
| ADDRESS | CH-4002 Basel |
| ENTITY | 99-Aktiengesellschaft |
| CITIZENSHIP | Switzerland |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | The colors lilac, green and light green are claimed as a feature of the mark. |
| DESCRIPTION OF MARK | The mark consists of the wording "VIJOICE" in lilac stylized font with seven circles in shades of green over the letters "ijoic" with circles making the dots over the letters "i" and "j" and with the circles changing in size and color from left to right from large to small and from green to light green. |
SECTION 66A INTERNATIONAL REGISTRATION DATA |
|
| INTL REG # | 1521536 |
| INTL REG DATE | 01/28/2020 |
| PRIORITY CLMD | YES |
| PRIOR CLMD DATE | 01/24/2020 |
| INTL STATUS | 001-REQUEST FOR EXTENSION OF PROTECTION PROCESSED |
| INTL STATUS DATE | 03/26/2020 |
| AUTO PROTECTION DATE | 09/26/2021 |
| INTL RENEWAL DATE | 01/28/2030 |
| INTL REG DEATH DATE | N/A |
| FIRST REFUSAL | YES |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 05/27/2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | 024 |
| 05/27/2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 023 |
| 05/27/2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 022 |
| 05/27/2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 021 |
| 05/27/2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 020 |
| 05/23/2020 | RFNT | P | REFUSAL PROCESSED BY IB | 019 |
| 05/18/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 018 |
| 05/17/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 017 |
| 05/17/2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 016 |
| 05/15/2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 015 |
| 05/15/2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 014 |
| 05/15/2020 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 013 |
| 05/15/2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 012 |
| 05/15/2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 011 |
| 05/15/2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | 010 |
| 05/04/2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 009 |
| 05/04/2020 | RFRR | P | REFUSAL PROCESSED BY MPU | 008 |
| 04/18/2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 007 |
| 04/17/2020 | CNRT | R | NON-FINAL ACTION WRITTEN | 006 |
| 04/15/2020 | DOCK | D | ASSIGNED TO EXAMINER | 005 |
| 04/07/2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | 004 |
| 04/03/2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 003 |
| 03/31/2020 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | 002 |
| 03/26/2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Maury M. Tepper, III |
| CORRESPONDENCE ADDRESS | Maury M. Tepper, III Tepper & Eyster, PLLC 3724 Benson Drive Raleigh, NC 27609 |
| DOMESTIC REPRESENTATIVE | Novartis Pharmaceuticals Corporation |